1. Home
  2. UPC vs CDT Comparison

UPC vs CDT Comparison

Compare UPC & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • CDT
  • Stock Information
  • Founded
  • UPC 1998
  • CDT 2019
  • Country
  • UPC China
  • CDT United States
  • Employees
  • UPC N/A
  • CDT N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPC Health Care
  • CDT Health Care
  • Exchange
  • UPC Nasdaq
  • CDT Nasdaq
  • Market Cap
  • UPC 2.1M
  • CDT 2.2M
  • IPO Year
  • UPC 2021
  • CDT N/A
  • Fundamental
  • Price
  • UPC $3.38
  • CDT $2.12
  • Analyst Decision
  • UPC
  • CDT
  • Analyst Count
  • UPC 0
  • CDT 0
  • Target Price
  • UPC N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • UPC 33.2K
  • CDT 469.7K
  • Earning Date
  • UPC 07-25-2025
  • CDT 08-11-2025
  • Dividend Yield
  • UPC N/A
  • CDT N/A
  • EPS Growth
  • UPC N/A
  • CDT N/A
  • EPS
  • UPC N/A
  • CDT N/A
  • Revenue
  • UPC $19,293,003.00
  • CDT N/A
  • Revenue This Year
  • UPC N/A
  • CDT N/A
  • Revenue Next Year
  • UPC N/A
  • CDT N/A
  • P/E Ratio
  • UPC N/A
  • CDT N/A
  • Revenue Growth
  • UPC N/A
  • CDT N/A
  • 52 Week Low
  • UPC $2.51
  • CDT $2.06
  • 52 Week High
  • UPC $2,423.88
  • CDT $622.50
  • Technical
  • Relative Strength Index (RSI)
  • UPC 42.03
  • CDT 32.79
  • Support Level
  • UPC $3.53
  • CDT $2.13
  • Resistance Level
  • UPC $3.96
  • CDT $2.46
  • Average True Range (ATR)
  • UPC 0.23
  • CDT 0.20
  • MACD
  • UPC 0.02
  • CDT 0.09
  • Stochastic Oscillator
  • UPC 23.08
  • CDT 10.87

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: